en · de · es · pt
melanotan-2-notes.peptides3626.com › Guide › Melanotan-2 Identity And Receptor Pharmacology — Worked Examples

Melanotan-2 Identity And Receptor Pharmacology — Worked Examples

By Editorial Desk · published 2026-06-23 · last reviewed 2026-07-23 · Guide

The short version of cyclic heptapeptide fits in a sentence. The long version — which is the one that helps — is below.

Reviewed 2026-07-23. Anything still debated is marked as such rather than presented as settled.

Melanotan-2 Identity and Receptor Pharmacology

Pharmacologically, melanotan-2 behaves as a non-selective agonist across the melanocortin receptor family. Binding at MC1R on dermal melanocytes promotes eumelanin synthesis, which underlies the tanning response described in early human work. Activity at the centrally expressed MC4R receptor is associated with reported effects on appetite and erectile function. Because the peptide does not discriminate strongly among receptor subtypes, attributing any single observed effect to one receptor pathway is generally not possible without selective antagonists or receptor knockout models.

Research interest has centred on photoprotection and pigmentation, with a smaller body of work on appetite and sexual function. Published human data remain limited to small, frequently uncontrolled studies, and the compound has never received marketing approval from a national medicines regulator. Most laboratory work treats it as a pharmacological tool for probing melanocortin signalling in cell culture or animal models. Whether pigmentation changes observed in people translate into measurable protection against ultraviolet-induced DNA damage remains an open question.

Peptide Identity and Structural Background

Structurally, Melanotan-2 retains the core recognition motif of alpha-melanocyte-stimulating hormone while adding a lactam bridge that links two side chains and constrains the molecule into a ring. This modification lowers susceptibility to enzymatic degradation. The compound acts as an agonist at melanocortin receptors, particularly subtypes associated with melanin production. Because the same receptor family influences several physiological processes, researchers note that its activity is not confined to pigmentation alone. Receptor selectivity continues to be examined in published studies.

Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its sequence incorporates modified residues that increase potency and extend biological activity relative to the native hormone. The compound binds receptors of the melanocortin family and is examined mainly in laboratory research. It does not occur naturally and exists only as a manufactured chemical entity produced by solid-phase synthesis.

Melanotan-2 at a glance

PropertyValueNotes
Common synonymsMelanotan II; MT-II; N-acetyl-norleucyl-cyclo[Asp-His-D-Phe-Arg-Trp-Lys] amideNaming follows peptide convention; the numeral distinguishes it from melanotan-1
Molecular formulaC50H69N15O9Includes the lactam bridge; no counter-ion assumed
Monoisotopic mass1023.53 DaFree base; salts and counter-ions shift the observed value
AppearanceWhite to off-white lyophilised powderBatch-to-batch colour variation is not itself proof of impurity
Typical analytical methodRP-HPLC purity determination with ESI-MS identity confirmationRetention time alone does not establish sequence identity

Chemistry and Receptor Pharmacology

Receptor-binding studies classify melanotan II as a non-selective melanocortin agonist. It interacts with MC1R, MC3R, MC4R and MC5R, with reported affinities in the low nanomolar range and no strong subtype preference. Activation of MC1R on dermal melanocytes shifts pigment synthesis toward eumelanin, the dark polymer deposited in melanosomes and transferred to keratinocytes. Because the same peptide engages MC4R in the hypothalamus, it also appears in animal work on food intake and erectile response, which is why it is discussed in both pigment and metabolic research. Which receptor populations dominate after systemic exposure in humans is not fully established.

Published pharmacokinetic information is limited and comes mainly from small studies rather than registrational trials. Plasma half-life is usually described as short, on the order of tens of minutes, followed by rapid tissue distribution and clearance of the intact peptide. Metabolites and low concentrations of parent compound have been reported in urine, a detail relevant to anti-doping and forensic testing. Whether repeated exposure changes receptor sensitivity or clearance over time remains an open question. Values differ noticeably between analytical assays, so published numbers should be read as approximate rather than definitive.

Related pages on this site

Background and Receptor Mechanism

Published human data come mostly from small, short studies rather than large controlled trials. Reported outcomes include increased skin pigmentation and, in some reports, effects on appetite and libido, but sample sizes are small and follow-up is limited. Whether long-term use produces durable pigment changes or adverse effects is not established. Because products sold outside pharmacies are not standardized, the actual content of any given vial is often unknown. Independent testing of such material is uncommon.

Melanotan II is a synthetic cyclic heptapeptide analog derived from the core sequence of alpha-melanocyte-stimulating hormone. Researchers at the University of Arizona synthesized it during the 1980s while studying pigmentation and appetite signaling. The compound is not an approved medicine in any major jurisdiction and appears mainly in laboratory and research-chemical settings. Its structure incorporates a lactam bridge between side chains, which constrains the ring and slows enzymatic breakdown relative to the natural hormone.

Background from the literature

== Transplantation and gene therapy == Hematopoietic stem cells (HSC) are cells in the bone marrow that can develop into all types of blood cells, including red blood cells, white blood cells, and platelets. There are two possible ways to treat hemoglobinopathies by targeting HSCs. One is to transplant HSCs from a healthy donor into the patient's bone marrow; this was pioneered in 1981. More recently, it has become possible to use CRISPR gene editing technology to modify the patient's own HSCs in a way that increases production of functional beta-globin chains, leading to near normal levels of healthy hemoglobin. All stem cell treatments must involve myeloablation of the patients' bone marrow in order to remove HSCs containing the faulty gene. This requires high doses of chemotherapy agents with side effects such as sickness and tiredness. A long hospital stay is necessary after infusion of the replacement HSCs while the cells take up residence in the bone marrow and start to make red blood cells with the stable form of haemoglobin.

A functional beverage is a drink marketed to highlight specific product ingredients or supposed health effects. Beverages marketed as "functional" include dairy drinks, sports and performance drinks, energy drinks, ready-to-drink teas, kombucha, "smart" drinks, fortified fruit drinks, plant milks, and enhanced water. Although these beverages may serve to hydrate a consumer, they have no proven health effects, and accordingly appear not to be "functional". For example, there is no good clinical evidence that kombucha provides any benefit to human health.

=== Origins === The Centre Party belongs to the political spectrum of "Political Catholicism" that, emerging in the early 19th century after the turmoil of the Napoleonic wars, had changed the political face of Germany. Many Catholics found themselves in Protestant dominated states. The first major conflict between the Catholic Church and a Protestant state was the "Colonian Church conflict", when the Prussian government interfered in the question of mixed marriages and the religious affiliation of children resulting from these. This led to serious aggressions against the Catholic population of the Rhineland and Westphalia and culminated in the arrest of the Archbishop of Cologne. At that time, one of the founding fathers of Political Catholicism was journalist Joseph Görres, who called upon Catholics to "stand united" for their common goals, "religious liberty and political and civil equality of the denominations". The conflict relaxed after 1840, with Frederick William IV's accession to the throne. The German revolutions of 1848–1849 brought new opportunities for German Catholics. In October, the bishops had their first meeting in 40 years in Würzburg and the local "Catholic Federations" assembled in Mainz to found the "Catholic Federation of Germany". In the National Assembly, which was convened to draw up a German constitution, a "Catholic club" was formed. This was not yet a comprehensive party, but a loose union aimed at protecting the Church's liberties in a future Germany, supported by many petitions from the "[Pope] Pius federations for religious liberty".

For type II and inverse type II dots, either the conduction or valence band of the core is located within the bandgap of the shell, which can lead to spatial separation of charge carriers in the core and shell. For all of these core/shell systems, the deposition of the outer layer can lead to potential lattice mismatch, which can limit the ability to grow a thick shell without reducing photoluminescent performance. One such reason for the decrease in performance can be attributed to the physical strain being put on the lattice. In a case where ZnSe/ZnS (type I) and ZnSe/CdS (type II) quantum dots were being compared, the diameter of the uncoated ZnSe core (obtained using TEM) was compared to the capped core diameter (calculated via effective mass approximation model) [lattice strain source] to better understand the effect of core-shell strain. Type I heterostructures were found to induce compressive strain and "squeeze" the core, while the type II heterostructures had the effect of stretching the core under tensile strain. Because the fluorescent properties of quantum dots are dictated by nanocrystal size, induced changes in core dimensions can lead to shifting of emission wavelength, further proving why an intermediate semiconductor layer is necessary to rectify lattice mismatch and improve quantum yield. One such core/double-shell system is the CdSe/ZnSe/ZnS nanocrystal. In a study comparing CdSe/ZnS and CdSe/ZnSe nanocrystals, the former was found to have PL yield 84% of the latter's, due to a lattice mismatch.

== Investigation == Mendonça's tutor called his parents because the child had not turned up for his 5:00 PM lesson, and they quickly initiated a search for him. Because Mendonça had told his mother that he was planning to meet up with his friend Dias, the police sought him for questioning. Dias was in an emotional state while being questioned, and simply replied that he did not know the boy's whereabouts, but that the police "should close the borders". Dias was interrogated by the police. Mendonça's cousin, João André Mendonça, recounted to the police that he, Mendonça and Dias had had a conversation where Dias had invited them to go meet up with a prostitute. The cousin said he had not joined Mendonça and Dias that afternoon because his mother would not let him leave the house. The police considered the possibility of kidnapping, slavery, homicide and suicide.

Sources: en.wikipedia.org

Further detail

=== Obesity and insulin resistance === Much of what is hypothesized about a resistin role in energy metabolism and T2DM can be derived from studies showing strong correlations between resistin and obesity, the premise being that serum resistin levels increase with increased adiposity. Conversely, serum resistin levels decline with decreased adiposity following medical treatment. Specifically, central obesity (waistline adipose tissue) is the region of adipose tissue that contributes most to rising levels of serum resistin. This is significant, considering the link between central obesity and insulin resistance, two marked peculiarities of T2DM. On the other hand, at least one study has found no correlation between resistin levels and obesity or insulin resistance in humans, so the resistin–insulin resistance connection may be regarded as somewhat unsettled. Although resistin levels increase with obesity, it is questioned whether this increase is responsible for the insulin resistance associated with increased adiposity. Several reports have shown a positive correlation between resistin levels and insulin resistance. This is supported by reports of correlation between resistin levels and subjects with T2DM. If resistin contributes to the pathogenesis of insulin resistance in T2DM, then designing drugs to promote decreased serum resistin in T2DM subjects may deliver therapeutic benefits.

=== Psychiatric disorders === Flutamide has been studied in the treatment of bulimia nervosa in women. Flutamide was found to be effective in the treatment of obsessive–compulsive disorder (OCD) in men with comorbid Tourette's syndrome in one small randomized controlled trial. Conversely, it was ineffective in patients with OCD in another study. More research is necessary to determine whether flutamide is effective in the treatment of OCD.

Packaged refrigerated or frozen red meat — to control pathogens (E. Coli O157:H7 and Salmonella) and to extend shelf life Packaged poultry — control pathogens (Salmonella and Camplylobacter) Fresh fruits, vegetables, and grains — to control insects and inhibit growth, ripening and sprouting Pork — to control trichinosis Herbs, spices and vegetable seasonings — to control insects and microorganisms Dry or dehydrated enzyme preparations — to control insects and microorganisms White potatoes — to inhibit sprout development Wheat and wheat flour — to control insects Loose or bagged fresh iceberg lettuce and spinach Crustaceans (lobster, shrimp, and crab) Shellfish (oysters, clams, mussels, and scallops)

Germany, officially the Federal Republic of Germany, is a country in Western and Central Europe. It lies between the Baltic Sea and the North Sea to the north with the Alps to the south. Its 16 constituent states have a total population of over 83 million, making it the most populous member state of the European Union (EU). Germany borders Denmark to the north; Poland and the Czech Republic to the east; Austria and Switzerland to the south; and France, Luxembourg, Belgium, and the Netherlands to the west. The nation's capital and most populous city is Berlin and its main financial centre is Frankfurt; the largest urban area is the Ruhr. Settlement in the territory of modern Germany began in the Lower Paleolithic, with various tribes inhabiting it from the Neolithic onward, chiefly the Celts, and Germanic tribes inhabiting the north. Romans named the area Germania. In 962, the Kingdom of Germany formed the bulk of the Holy Roman Empire. During the 16th century, northern German regions became the centre of the Protestant Reformation. Following the Napoleonic Wars and the dissolution of the Holy Roman Empire in 1806, the German Confederation was formed in 1815. Unification of Germany into the modern nation-state, led by Prussia, established the German Empire in 1871. After World War I and a revolution, the Empire was replaced by the Weimar Republic. The Nazi rise to power in 1933 led to the establishment of a totalitarian dictatorship, World War II, and the Holocaust.

Sources: en.wikipedia.org

Frequently asked questions

What is melanotan-2 chemically?

It is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone, containing seven amino acids with a lactam ring and a D-configured phenylalanine residue. It is supplied as a lyophilised powder for laboratory research.

How does it differ from the natural hormone?

The natural hormone is a linear tridecapeptide that is rapidly degraded in circulation. Melanotan-2 is shortened, cyclised, N-terminally acetylated, and carries a D-amino acid substitution, all of which slow enzymatic breakdown.

Does it hold any regulatory approval?

No national medicines regulator has approved melanotan-2 for therapeutic or cosmetic use. In several jurisdictions it is treated as an unapproved prescription medicine, and its legal classification differs from country to country.

What is Melanotan-2 chemically?

It is a synthetic cyclic heptapeptide and an analogue of alpha-melanocyte-stimulating hormone. The molecule is produced by chemical synthesis rather than extracted from a biological source.

Network